Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,580.25
    -1,691.15 (-3.36%)
     
  • CMC Crypto 200

    1,260.80
    -97.20 (-7.16%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

We must fight gender inequality in healthcare research

<span>Photograph: Manjurul Haque/Alamy</span>
Photograph: Manjurul Haque/Alamy

Jessica Nordell raises several important issues facing women and people from ethnic minorities in accessing quality healthcare (The bias that blinds: why some people get dangerously different medical care, The long read, 21 September). Another important factor is that less is known about women’s health than men’s. A recent analysis of the US National Institutes of Health expenditure (by far the largest funder of health research in the world) concluded that the “NIH applies a disproportionate share of its resources to diseases that affect primarily men, at the expense of those that primarily affect women”. The biggest losers? ME/chronic fatigue syndrome and migraine, funded respectively at 6% and 7% commensurate with the disease burden on patients.

Unless metrics relating to discrepancies between the treatment of men and women in all aspects of healthcare are monitored, and those responsible held to account, women will continue to suffer unnecessarily poor health.
Silvia Hummel
Keswick, Cumbria

Have an opinion on anything you’ve read in the Guardian today? Please email us your letter and it will be considered for publication.